Company intelligence / Profile preview
Northwest Biotherapeutics
Bethesda, Maryland, United States
- Ownership
- Public · NWBO
- Employees
- ~25
- Development stage
- Phase 3
01
Overview
Northwest Biotherapeutics’ lead product candidate DCVax-L has completed a 331-patient Phase III trial for glioblastoma multiforme. Results have been published in JAMA Oncology and presented at scientific meetings. The company has submitted a Marketing Authorization Application (MAA) for commercial approval of DCVax-L. DCVax-Direct completed a Phase I trial for inoperable solid tumors and may advance to Phase II as resources permit. The company previously conducted early trials with DCVax-L for advanced ovarian cancer
- Therapeutic areas
- Oncology
- Modalities
- Dendritic cell-based vaccines (cell therapy/immunotherapy)
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships disclosed; prior collaborations with academic centers such as University of California Los Angeles and University of Pennsylvania are noted.
04
Financials
- Market cap
- $271.6M
- Total revenue
- $807K
- Enterprise value
- $327.4M
Beyond the preview
Go deeper on Northwest Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Northwest Biotherapeutics.